4//SEC Filing
JENSEN JESSICA D. 4
Accession 0001104659-23-039353
CIK 0001811764other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 8:08 PM ET
Size
5.4 KB
Accession
0001104659-23-039353
Insider Transaction Report
Form 4
JENSEN JESSICA D.
EVP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2023-03-28+136,055→ 136,055 totalExercise: $6.78Exp: 2029-03-28→ Common Stock (136,055 underlying)
Footnotes (1)
- [F1]The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868742
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 8:08 PM ET
- Size
- 5.4 KB